Shryock Christopher P 4
4 · Medline Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Medline CHRO Christopher Shryock Receives Stock Awards
What Happened
- Christopher P. Shryock, Chief Human Resources Officer of Medline (MDLN), received equity awards reported on a Form 4 filed March 6, 2026. The filing shows grants totaling 548,590 units: 11,903 restricted stock units (RSUs) (acquired 2026-03-05 at $0.00) and two derivative incentive-unit grants of 496,049 and 40,638 units (recorded 2025-12-16; reported as derivative acquisitions with no per-share price).
- The derivative awards are “Incentive Units” (profit-interest style units) that can convert into common units and, under an exchange agreement, into Class A common stock. No cash purchase or sale occurred—these are awards/derivative grants, not open-market buys or sales.
Key Details
- Transaction dates/prices: 2026-03-05 — 11,903 RSUs @ $0.00 (acquired); 2025-12-16 — 496,049 and 40,638 incentive units (derivative acquisitions; price shown as N/A).
- Total units reported: 548,590 (11,903 RSUs + 536,687 incentive units).
- Shares owned after transaction: not specified in the provided filing excerpt; see full Form 4 for total holdings.
- Vesting and conversion notes:
- RSUs (11,903): 25% vest June 15, 2026; remaining 75% vest in three equal annual installments beginning March 1, 2027. (Footnote F1)
- Incentive Units: profit-interest style units convertible to common units, then exchangeable 1-for-1 for Class A shares per a Dec 16, 2025 exchange agreement; no expiration. (F2, F3)
- One set of Incentive Units: 20% vested; remaining 80% vest in four equal annual installments beginning Sept 27, 2026. (F5)
- Other Incentive Units: vest in five equal annual installments beginning March 28, 2026. (F6)
- These derivative interests were part of a pre-IPO reclassification previously reported on the insider’s Form 3 (filed Dec 17, 2025). (F4)
- Filing timeliness: Form 4 was filed March 6, 2026 for transactions dated Dec 16, 2025 and Mar 5, 2026 — this is later than the standard two-business-day Form 4 reporting window.
Context
- These entries reflect awards and convertible/derivative interests, not purchases or sales. Incentive Units are tied to future value and conversion mechanics (they have characteristics like stock appreciation rights) and will only translate into publicly traded Class A shares under the conversion/exchange rules described in the footnotes.
- For retail investors: awards/vesting schedules indicate potential future dilution and alignment of executive compensation with stock performance, but they do not by themselves indicate immediate buying or selling by the insider.
Insider Transaction Report
Form 4
Medline Inc.MDLN
Shryock Christopher P
Chief Human Resources Officer
Transactions
- Award
Class A Common Stock
[F1]2026-03-05+11,903→ 11,903 total - Award
Incentive Units of Medline Holdings, LP
[F2][F3][F4][F5]2025-12-16+496,049→ 496,049 total(indirect: See Footnote)Exercise: $24.19→ Class A Common Stock (496,049 underlying) - Award
Incentive Units of Medline Holdings, LP
[F2][F3][F4][F6]2025-12-16+40,638→ 40,638 total(indirect: See Footnote)Exercise: $27.68→ Class A Common Stock (40,638 underlying)
Footnotes (6)
- [F1]Represents a grant of restricted stock units, of which 25% vest on June 15, 2026 and the remaining 75% vest in three equal annual installments beginning on March 1, 2027.
- [F2]Reflect incentive units of Medline Holdings, LP ("Incentive Units"), which are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of common units of Medline Holdings, LP ("Common Units") generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of the Issuer's Class A common stock ("Class A Common Stock")) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.
- [F3](Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of an exchange agreement, dated as of December 16, 2025. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.
- [F4]These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025.
- [F5]20% of these Incentive Units have vested, and the remaining 80% vest in four equal annual installments beginning on September 27, 2026.
- [F6]These Incentive Units vest in five equal annual installments beginning on March 28, 2026.
Signature
/s/ Nicole Fritz, Attorney-in-Fact|2026-03-06